|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项
' w+ I3 w! U4 ~1 V01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.
4 z' Y! |! z5 u% S* x+ d02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor.
. [0 w% c$ M0 }8 S03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity., A( `2 {. ~' E1 {- J
04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.
" q% ~! J, p+ T- ]) u2 Q; w. l05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.
$ t6 T0 s7 P; K& l0 o06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.
6 L, |5 o- m+ ]$ p$ F0 m8 Z* I07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.; W- p# G" Q9 R8 T! N
08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.
- l u. h4 T# | d# K09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.
7 l& V% N2 g5 w1 T# c8 w10.Interpretable machine learning for prostate biopsy: Cohort study.5 T9 W$ V1 H6 x1 r- Q; Z
11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.. J: K. g( G; Y; c( N
12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.
; k. p# g7 c* _; a( u0 I9 w13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).& E, o s5 c2 B, M: N
14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).: Q- V3 W/ F! e
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.
6 \4 p; N- D; V) x16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.
) c6 v8 ]. B6 O) `5 p) _17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors." y! z) D4 _9 |/ T. B
18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.7 k. H& ~4 M; H6 U
19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.
5 e9 j6 [5 H0 i1 F% |+ I0 `20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.
. k! h6 F1 e: w0 A- a# [3 X21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021. t) F/ E( ?) X" e8 m0 a' i5 N
22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.
( g/ I! D7 }' s* b. p* b23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.
5 ~) `% R) M7 n0 C+ @24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.
3 `# I/ Z6 o9 m. x5 Q9 [& t6 [0 L$ v25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.
5 G9 U7 J' x! g |
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
